6-[18F]Fluorodopamine ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
6. Parkinson disease
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00775853 (ClinicalTrials.gov) | May 27, 2009 | 17/10/2008 | Biomarkers of Risk of Parkinson Disease | Biomarkers of Risk of Parkinson Disease | Parkinson Disease;Autonomic Nervous System Diseases;Pure Autonomic Failure | Drug: 6-[18F]Fluorodopamine;Drug: 6-[18F]Fluorodopa;Drug: 13N-Ammonia | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Completed | 18 Years | 70 Years | All | 89 | United States |